CNS Pharmaceutical: Funding, Investors & Team (Oct 2026)
CNS Pharmaceuticals is a biotechnology company in the early stages of research focused on creating new therapies for brain tumors. The company is considering expanding its research to explore the potential use of Berubicin in treating other diseases such as pancreatic and ovarian cancers and lymphoma, as well as developing combination therapies involving Berubicin.
CNS Pharmaceutical has raised $31.9M across 4 funding rounds on record, the most recent an undisclosed round of $22.5M announced in May 2026.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
CNS Pharmaceutical Company Profile and Key Stats
Latest funding round on record: May 2026.
CNS Pharmaceutical Funding Rounds
CNS Pharmaceutical raised $1.4M in an undisclosed round announced in Jun 2024.
4 months later, an undisclosed round of $3.0M was announced in Oct 2024.
7 months later, an undisclosed round of $5.0M was announced in May 2025.
1 years later, an undisclosed round of $22.5M was announced in May 2026.
CNS Pharmaceutical Founders and Leadership Team
Contact details for the CNS Pharmaceutical team: 1 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →CNS Pharmaceutical Funding Compared to Other Biotechnology Startups
CNS Pharmaceutical's latest round of $22.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like CNS Pharmaceutical in Biotechnology and Houston
Companies Similar to CNS Pharmaceutical
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
CNS Pharmaceutical Funding FAQs
What does CNS Pharmaceutical do?
CNS Pharmaceuticals is a biotechnology company in the early stages of research focused on creating new therapies for brain tumors. The company is considering expanding its research to explore the potential use of Berubicin in treating other diseases such as pancreatic and ovarian cancers and lymphoma, as well as developing combination therapies involving Berubicin.
How much funding has CNS Pharmaceutical raised?
CNS Pharmaceutical has raised $31.9M across 4 rounds on record. The most recent is an undisclosed round of $22.5M announced in May 2026.
When did CNS Pharmaceutical last raise funding?
CNS Pharmaceutical's most recent funding round on record is an undisclosed round of $22.5M, announced in May 2026.
Who founded CNS Pharmaceutical?
FundedIQ lists John Climaco (Founder), Rami Levin (Founder) at CNS Pharmaceutical.
Where is CNS Pharmaceutical headquartered?
CNS Pharmaceutical is based in Houston, Texas, United States.
How many employees does CNS Pharmaceutical have?
CNS Pharmaceutical is in the 1-10 employee band.
How does CNS Pharmaceutical's funding compare to other Biotechnology startups?
CNS Pharmaceutical's latest round of $22.5M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's CNS Pharmaceutical Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for CNS Pharmaceutical is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.